Showing 1 - 20 results of 471 for search '"Nelson EL"', query time: 1.19s Refine Results
1
Academic Journal
2
Electronic Resource
4
Electronic Resource
7
9

Source: Ghochikyan, A; Pichugin, A; Bagaev, A; Davtyan, A; Hovakimyan, A; Tukhvatulin, A; et al.(2014). Targeting TLR-4 with a novel pharmaceutical grade plant derived agonist, Immunomax (R), as a therapeutic strategy for metastatic breast cancer. JOURNAL OF TRANSLATIONAL MEDICINE, 12. doi: 10.1186/s12967-014-0322-y. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/8x2649r3

File Description: application/pdf

11

Authors: Nelson, EL

Source: Nelson, EL. (2014). HER2/neu: An increasingly important therapeutic target: Part 3 Clinical Applications & Investigations. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/6x26q0cc

File Description: application/pdf

12

Authors: Nelson, EL

Source: Nelson, EL. (2014). HER2/neu:An Increasingly Important Therapeutic Target: Part 2 Distribution of HER2/neu Overexpression and Gene Amplification by Organ, Tumor Site and Histology.. Clinical Investigation. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/1tn444mg

File Description: application/pdf

13

Authors: Nelson, EL, Nelson, E

Source: Nelson, EL; & Nelson, E. (2014). An increasingly important therapeutic target: Part 2 Distribution of HER2/neu Overexpression and Gene Amplification by Organ, Tumor Site and Histology. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/8kb0k91z

File Description: application/pdf

14

Source: Martinez, M; Ono, N; Planutiene, M; Planutis, K; Nelson, EL; & Holcombe, RF. (2013). Correction to Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy [Cancer Cell International 13, (80) 2013] DOI:10.1186/1475-2867-13-80. Cancer Cell International, 13(1). doi: 10.1186/1475-2867-13-80. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/5n65s0wk

File Description: application/pdf

15
Electronic Resource
16
Electronic Resource
17
18

Source: European journal of immunology, vol 30, iss 4
Boehlk, S; Fessele, S; Mojaat, A; Miyamoto, NG; Werner, T; Nelson, EL; et al.(2000). ATF and Jun transcription factors, acting through an Ets/CRE promoter module, mediate lipopolysaccharide inducibility of the chemokine RANTES in monocytic Mono Mac 6 cells.. European journal of immunology, 30(4), 1102-1112. doi: 10.1002/(sici)1521-4141(200004)30:4<1102::aid-immu1102>3.0.co;2-x. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/8881w3qs

File Description: application/pdf

19

Source: Nelson, EL; Strobl, S; Subleski, J; Prieto, D; Kopp, WC; & Nelson, PJ. (1999). Cycling of human dendritic cell effector phenotypes in response to TNF-alpha: modification of the current 'maturation' paradigm and implications for in vivo immunoregulation.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 13(14), 2021-2030. doi: 10.1096/fasebj.13.14.2021. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/5vb1v0nx
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, vol 13, iss 14
Europe PubMed Central

File Description: application/pdf

20
Periodical